• Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

    Nov 1, 2015, 00:00
  • Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma

    Nov 1, 2015, 00:00
  • Espesor Corneal Central En Personas Sanas En Chile Y Correlación Entre Distintos Métodos De Medición

    Nov 1, 2015, 00:00
  • Evaluation Study on Equalization of Basic Medical and Health Services in China

    Nov 1, 2015, 00:00
  • Acrysof Cachet Para la Corrección de Moderada a Alta Miopía- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00
  • Improved Visual Function Is Associated With Inflammation Reduction In Subjects With Non-Infectious Uveitis (Niu) of The Posterior Segment Treated With Intravitreal Sirolimus- ResultsFrom Sakura Study 1

    Nov 1, 2015, 00:00
  • A Pct-Algorithm To Guide Antibiotic Therapy In Patients Hospitalized With Copd Exacerbations Leads To Net Cost Savings By Reducing Frequency And Duration Of Antibiotic Use As Compared To Current Practice

    Nov 1, 2015, 00:00
  • A Systematic Review of Herpes Zoster Vaccine Acceptance

    Nov 1, 2015, 00:00
  • Economic Analysis of Paliperidone Long-Acting Acting Injectable for Chronic Schizophrenia in Portugal

    Nov 1, 2015, 00:00
  • One-Year Cost-Comparison Analysis Of Absorb™ Everolimus Eluting Bioresorbable Vascular Scaffold And Xience™ Everolimus Eluting Stent- Based On Findings From Absorb Ii

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Alternative Strategies Of Monitoring For Amiodarone-Related Thyroid Toxicity In Uk Primary Care

    Nov 1, 2015, 00:00
  • The Economic Burden Of Poor Adherence To Statins In Belgium

    Nov 1, 2015, 00:00
  • Antidepressant use in Patients with Major Depressive Disorder- a Comparison of Treatment Resistant and Non-Treatment Resistant Episodes in the United Kingdom Using The Cprd Database

    Nov 1, 2015, 00:00
  • Efetividade E Segurança Da Glargina Vs Detemir E Nph No Tratamento De Pacientes Com Diabetes Tipo 1 – Revisão Sistemática E Metanálise

    Nov 1, 2015, 00:00
  • Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis- Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and S ...

    Nov 1, 2015, 00:00
  • Patterns Of Metachronous Metastases After Curative Treatment Of Breast Cancer

    Nov 1, 2015, 00:00
  • Cost Per Qaly as a Potential Hurdle in Accessibility to Innovative Cancer Care in Selected Cee Countries

    Nov 1, 2015, 00:00
  • Factors Associated with the Risk of Diabetes-Related Events- A Retrospective Analysis

    Nov 1, 2015, 00:00
  • Engaging Hispanic Caregivers in Research- A Framework to Design Culturally Sensitive Approaches for Engagement in Patient-Centered Outcomes Research

    Nov 1, 2015, 00:00
  • Investigating The Health-Economic Impact Of Biomarker-Driven Immunosuppression (Biodrim) Following Renal Transplantation

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of the Information Technology Aided Relaps Prevention Programme in Schizophrenia (Itareps) in the Czech Republic

    Nov 1, 2015, 00:00
  • Epidemiological Data Presented in German Benefit Assessments – A Comparison between Pharmaceutical Companies and G-Ba

    Nov 1, 2015, 00:00
  • Lipegfilgrastim For Reduction Of Chemotherapy-Induced Neutropenia Related Events- A Meta-Analysis

    Nov 1, 2015, 00:00
  • A Comparison of on-Patent Medicine Prices Using An Eks Method

    Nov 1, 2015, 00:00
  • Adoption Of Transcatheter Aortic Valve Replacement In Germany- Utilization Patterns And Case Volumes Compared To Surgical Aortic Valve Replacement In The Period 2009-2013

    Nov 1, 2015, 00:00
  • Ideglira Improves Health Utility Compared With Insulin Glargine In Patients With Type 2 Diabetes

    Nov 1, 2015, 00:00
  • From Centralized Marketing Authorization to National Reimbursement – A Challenging Journey for New Medical Products with Placebo Controlled Trials

    Nov 1, 2015, 00:00
  • Cost-Consequences Analysis Of Fesoterodine At Flexible-Dose In The Therapy Of Overactive Bladder In Routine Medical Practice

    Nov 1, 2015, 00:00
  • A Five-Year Model to Assess The Cost-Effectiveness of New Diagnostic Tests In The Early Diagnosis of Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Research And Evaluation of the Self-Treatment Process with the Non-Steroidal Anti- Inflammatory Drugs in the Republic of Armenia

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Edoxaban Compared With Warfarin For The Prevention Of Stroke And Systemic Embolic Events In The Uk

    Nov 1, 2015, 00:00
  • The Treatment Patterns Of Castration Resistant Prostate Cancer In Japan

    Nov 1, 2015, 00:00
  • Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00
  • Methodological Guidelines for Economic Drug Evaluation Studies in Portugal- Major Gaps and New Topics in the Studies Evaluated Between 2010 and 2014

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Idelalisib In Combination With Rituximab For The Treatment Of Relapsed/Refractory Chronic Lymphocytic Leukemia (Cll) In Portugal

    Nov 1, 2015, 00:00
  • Changes In The Mortality Rate During The Last Decade In The Fields Of Oncology In Hungary

    Nov 1, 2015, 00:00
  • Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intoleran An Economic Evaluation

    Nov 1, 2015, 00:00
  • The Cost Of Acute Care Hospitalizations Associated With Chronic Heart Failure In Canada

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Dasatinib as a Second-Line Therapy in Patients with Chronic Myelogenous Leukemia (Cml) in the Russian Federation

    Nov 1, 2015, 00:00
  • Network Meta-Analysis of Biological Response Modifiers in Rheumatoid arthritis Including real World Evidence at Multiple time Points

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis- Analysis Of Cost-Effectiveness Of Lanthanum-Carbonate (Lc) In Uncontrolled Hyperphosphatemia In Dialysis

    Nov 1, 2015, 00:00
  • Health Care Resource Utilization and Direct Medical Cost for Patients With Osteoporotic Fractures In Tianjin, China

    Nov 1, 2015, 00:00
  • Revealed Opportunism- How Physicians Game Prior Authorization Protocols Until They Are Rescinded

    Nov 1, 2015, 00:00
  • Relationship Between Gpx1 Pro198leu Polymorphism and Susceptibility of Kashin-Beck Disease

    Nov 1, 2015, 00:00
  • Direct And Indirect Costs Associated to Retinal Vascular Diseases In Italy. A Probabilistic Cost of Illness Study

    Nov 1, 2015, 00:00
  • A Discrete Choice Experiment (Dce) To Elicit Preferences For Attributes Of A Bedside Pharmacogenetic Test – Preliminary Results

    Nov 1, 2015, 00:00
  • Analysis of Evaluations Made by the uk Cancer Drug Fund Panel of Breast Cancer Treatments in Relation to Overall Scores and Final Cdf Decisions

    Nov 1, 2015, 00:00
  • Long Term Virological Outcomes of Hiv Infected Patients on Antiretroviral Treatment In Uganda

    Nov 1, 2015, 00:00
  • Best Practices for Network Meta-Analysis Methodology- Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00
  • Are Trends in Spending on Oncology Treatments Sustainable?- Analysis of Sales Patterns in Major Global Markets

    Nov 1, 2015, 00:00
  • Self-Reported Medication Costs In Patients Receiving Sacral Neuromodulation For Overactive Bladder

    Nov 1, 2015, 00:00
  • Real-World Effectiveness of Amlodipine/Valsartan/Hydroclorothiazide Single-Pill Combination in the Treatment of Patients with Essential Hypertension

    Nov 1, 2015, 00:00
  • Potential For Cost Savings Associated With A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- Italian Perspective

    Nov 1, 2015, 00:00
  • Health-Related Quality of Life in Patients with Localized Prostate Cancer Using Eq- 5d- 3l

    Nov 1, 2015, 00:00
  • Colorectal Cancer- the Importance of Being Right – a Model Investigating the Impact of Bowel Cleansing on Adenoma Detection in a German Screening Population

    Nov 1, 2015, 00:00
  • How To Capture And Reward The Benefits Associated With Companion Diagnostics?

    Nov 1, 2015, 00:00
  • Psychometric Analysis And Validation of The Patient Satisfaction With Orthopaedic And Prosthetic Medical Devices, Modul Client Satisfaction With Device (Csd)

    Nov 1, 2015, 00:00
  • Extended-Release Oxycodone Hydrochloride (Oxycontin®) for Cancer Pain Management- a Cost Analysis from the Brazilian Public and Private Healthcare Systems Perspectives

    Nov 1, 2015, 00:00
  • Impacto En La Supervivencia De La Gestion Y Atencion De Pacientes Con Cáncer De Prostata. Instituto De Cancerología Las Américas, Medellín (Colombia), 2013

    Nov 1, 2015, 00:00
  • Could Giving Cost-Utility Hta Bodies Negotiating Powers Help Bridge The Gap between Cost-Containment and Broadening Coverage? A Systematic Review of all Swedish Nlt Appraisals of Hospital Pharmaceuticals

    Nov 1, 2015, 00:00
  • Re-Evaluating The Cost-Effectiveness of Screening For Congenital Adrenal Hyperplasia (Cah)- The Sensitivity to Choice of Distributions In Probabilistic Sensitivity Analyses (Psas)

    Nov 1, 2015, 00:00
  • A National Eq-5d Value Set for Hungary - a Model Methodology ?

    Nov 1, 2015, 00:00
  • A Management View On Health Economics - Case Study On Network Meta Analyses (Nma) For Pulmonary Arterial Hypertension (Pah)

    Nov 1, 2015, 00:00
  • “Efficacy and Safety Bariatric Surgery VS. Clinical Treatment in Control of Levels Glycemic and Remission Diabetes Mellitus Type II in Patients Obese”

    Nov 1, 2015, 00:00
  • Cost Offsets Associated With Rebif Use In First-Line Rrms- An Analysis Based on The Cochrane Collaboration Review And Real-World Persistence Data

    Nov 1, 2015, 00:00
  • Efficiency Of Expenses Of Gefitinibum In Patients With Non-Small Cell Lung Cancer As A Second Line Therapy

    Nov 1, 2015, 00:00
  • Financial Impact of Hospital Expenditure In Chronic Diseases For Seguro Popular

    Nov 1, 2015, 00:00
  • State of The Art of Medical Registers In Switzerland 2015- More Questions Than Answers

    Nov 1, 2015, 00:00
  • Burden Of Residual Skin and Joint Disease in Patients with Psoriatic Arthritis Treated with Biologics

    Nov 1, 2015, 00:00
  • The Effect Of Glucose Lowering Drug Use On Overall Mortality Among Breast Cancer Patients

    Nov 1, 2015, 00:00
  • Cost Analysis of Certolizumab Pegol Compared With Available Biologic Agents For Crohn’s Disease In Mexico And Brazil

    Nov 1, 2015, 00:00
  • Estimating the Opportunity Costs of Treating Meningitis in Selected Countries of Latin America

    Nov 1, 2015, 00:00
  • A Method to Evaluate Uncertainty Due to Unknown Parameter Correlation in Stochastic Decision Models

    Nov 1, 2015, 00:00
  • Attitudes of Medical Doctors And Pharmacists Toward Generic Substitution In Slovakia- First Results From Adopting The Law In 2012

    Nov 1, 2015, 00:00
  • A Decision Tree Model To Evaluate The Costs And Consequences Of Using Dual Antibiotic Bone Cement Versus Single Antibiotic Bone Cement In Hip Hemiarthroplasty

    Nov 1, 2015, 00:00
  • Resource Use Measurement In Trials Conducted In Care Homes- A Study Of Level-Of-Agreement Between Data Collected From Gp Records And Care Home Records

    Nov 1, 2015, 00:00
  • Prevalence and Cost of Myasthenia Gravis In The Medicare Beneficiary Sample

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of The Use of 18fdg-Pet/Ct In The Detection of Recurrent Differentiated Thyroid Cancer

    Nov 1, 2015, 00:00
  • Age-Rationing - Reality or Virtue? A Study in Autoimmune Disease

    Nov 1, 2015, 00:00
  • Comparative Analysis of Physical Activity, Sense of Control And Self-Reported Health of Elderly In Cee Countries

    Nov 1, 2015, 00:00
  • Impact on Time Gap Between Approval and Reimbursement of Target Therapy to Advanced Colorectal Cancer

    Nov 1, 2015, 00:00
  • Assessment Of Patient-Reported Health Status In Chronic Thromboembolic Pulmonary Arterial Hypertension Patients Treated With Riociguat- 2-Year Results From The Chest-2 Extension Study

    Nov 1, 2015, 00:00
  • Horizontal Vs. Vertical Equity- Market Access of Orphan Drugs In France and Uk

    Nov 1, 2015, 00:00
  • The New Technology Cost-Effectiveness Checklist- Introducing A Practical Guideline For The Selection Of Health Technologies

    Nov 1, 2015, 00:00
  • The Role of Patient Level Data In Assessing Health Economic Value- A Case Study Using Edge and The Core Diabetes Model

    Nov 1, 2015, 00:00
  • Modeling The Cost-Effectiveness of Ilaprazole Vs. Omeprazole for The Treatment of Newly Diagnosed Duodenal Ulcer Patients In China

    Nov 1, 2015, 00:00
  • Something Old, Something Borrowed, Something New- a Direct Comparison of Three Qualitative Elicitation Methods

    Nov 1, 2015, 00:00
  • Demographics, Clinical Characteristics, and Treatment Patterns of Patients Newly Started on Prostacyclin Therapy for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00
  • Effect of Transfer Factor on The Reduction of The Number of Episodes of Recurrent Infections In Adult And Pediatric Patients From A Multicentre Observational Study

    Nov 1, 2015, 00:00
  • Sun Exposure in Mexico- an Observational Study on Population Habits and Knowledge of Risks Associated with Such Exposure

    Nov 1, 2015, 00:00
  • Reimbursement of Telemedicine in Germany- Quo Vadis - Anything Beyond Selective Contracts?

    Nov 1, 2015, 00:00
  • Effects Of Nutritional Supplement Usage On Mortality In Colorectal Cancer Patient With Abdominal Resection Surgery

    Nov 1, 2015, 00:00
  • Long-Acting Insulin Analogues A Systematic Review of Systematic Reviews

    Nov 1, 2015, 00:00
  • Systematic Review Of Hyperkalemia Due To Angiotensin Enzyme Converting Inhibitors

    Nov 1, 2015, 00:00
  • Mortality Reduction From Gastric Cancer By Endoscopic Screening- 6-Years Follow-Up Of A Population-Based Cohort Study

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of Rheumatoid Arthritis In Europe

    Nov 1, 2015, 00:00
  • Analysis of Government Procurements of Medicines for Rare Diseases In Russia

    Nov 1, 2015, 00:00
  • Muscular Dystrophy Patients With Severe Renal Dysfunction- Analysis Of Ace-Inhibitor Use

    Nov 1, 2015, 00:00
  • Estimating The Economic Burden Of Stroke In South India - A Cost-Of-Illness Study

    Nov 1, 2015, 00:00
  • International Diabetes Management Practice Study (Idmps)- Resource Use Associated With Type 2 Diabetes In Africa, Middle East, South Asia, Eurasia and Turkey

    Nov 1, 2015, 00:00
  • Isolation, Identification And Antimicrobial Susceptibility Testing of Salmonella From Selected Poultry Farms In Debre Zeit

    Nov 1, 2015, 00:00
  • A Dynamic Model To Estimate The Budget Impact Of A Neumococcal Vaccination Program In Spain

    Nov 1, 2015, 00:00
  • Validation of Fracture Risk Model In Japanese Women Compared With Frax

    Nov 1, 2015, 00:00
  • Evicel and Bloodless Protocol In Orthopaedics Surgery Clinical Evidence And Cost- Analysis - Italian Experience Humanitas Research Hospital

    Nov 1, 2015, 00:00
  • Including Human Resource Constraints In Health Economic Evaluations

    Nov 1, 2015, 00:00
  • Bone Pain And Bone Targeting Agent (Bta) Treatment Pattern In Patients With Bone Metastases (Bms) From Prostate Cancer (Pc) In Real World Setting In Europe

    Nov 1, 2015, 00:00
  • Assessment Of Renal Function Among Patients With Bone Metastases From Solid Tumors

    Nov 1, 2015, 00:00
  • Drug Utilization Pattern of Lisdexamfetamine Dimesylate in Europe

    Nov 1, 2015, 00:00
  • Costo Efectividad de la Terapia Inmunomoduladora en Esclerosis Multiple Tipo Recaída Remision- Busqueda Sistemática de la Literatura

    Nov 1, 2015, 00:00
  • The Italian 648/96 List- Approvals, Rejections and Methods In Aifa’s Evaluation Process Between January 2013 and May 2015

    Nov 1, 2015, 00:00
  • Sickness Funds Data Analyses on Prevalence Incidence And Treatment of Waldenstrom’s Macroglobulinemia (Wm) In Germany

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Apremilast In Patients With Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Prostata En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00
  • Radio-223 in the Treatment of Metastatic Castration Resistant Prostate Cancer with Bone Metastases- Budget Impact Analysis of the National Health Service

    Nov 1, 2015, 00:00
  • Medication Error Identification Rate Among Medical Students of Quetta City, Pakistan

    Nov 1, 2015, 00:00
  • Health Related Quality Of Life In A Community Dwelling Elderly Sample In Brazil

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain

    Nov 1, 2015, 00:00
  • Association Between Feeding Types and Iron Status In India

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece

    Nov 1, 2015, 00:00
  • Change In The Demographic Profile And Impact In The Mortality Of Melanoma And Lung Cancer In Puerto Rico 2000-2010

    Nov 1, 2015, 00:00
  • Cost Effectiveness of Multidisciplinary Pain Management Services for Chronic Back Pain- Systematic Review

    Nov 1, 2015, 00:00
  • Patient, Caregiver and Treatment Factors Associated with Medication Satisfaction Among Treated Patients in the Caregiver Perspective on Pediatric Adhd (Cappa) Study in Europe

    Nov 1, 2015, 00:00
  • Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents

    Nov 1, 2015, 00:00
  • Evaluation of The Annual Cost of Fixed-Dose Combination Drugs Used In Treatment of Hypertension In India- An Economic Perspective

    Nov 1, 2015, 00:00
  • Economic Evaluation Of The Use Of Human Albumin In A Brazilian Public Hospital

    Nov 1, 2015, 00:00
  • Humanistic Burden in Dementia- Which Tools Were Most Commonly Used in Studies Published in Pubmed in 2014?

    Nov 1, 2015, 00:00
  • Políticas de Acesso ao Medicamento no Sistema Público de Saúde no Brasil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Early Parenteral Versus Enteral Nutrition In Critically Ill Patients

    Nov 1, 2015, 00:00
  • Vedolizumab In Ulcerative Colitis; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00
  • Sick-Pay Expenditures In Hungary According To Major Disease Groups

    Nov 1, 2015, 00:00
  • Costo Efectividad De La Adici”N De Bevacizumab Al Esquema De Primera Línea De Quimioterapia Carboplatino + Paclitaxel En Pacientes Con Cáncer De Pulm”N De Celula No Pequeña No Escamosa Con Ecog Entre 0 Y 1

    Nov 1, 2015, 00:00
  • Indiscriminate Prescription of Antibiotics and an Urgent Need of Legislation- A Survey from Pakistan

    Nov 1, 2015, 00:00
  • A Systematic Review To Assess The Association Between The Use Of Antidepressants And Male-Only Cancers

    Nov 1, 2015, 00:00
  • Costs And Cost-Effectiveness Of Non-Invasive Prenatal Diagnosis (Nipt) For Detection Of Trisomy 21 In Sweden

    Nov 1, 2015, 00:00
  • Assessment of Content Equivalence and Usability Between the Paper and Electronic Versions of the Psoriasis Symptom and Sign Diary (Pssd) Among Subjects with Plaque Psoriasis

    Nov 1, 2015, 00:00
  • Systematic Review On Efficacy Of The F-18 Fluoromisonidazole Pet Or Pet/Ct

    Nov 1, 2015, 00:00
  • The Burden of Cancer in Emerging Economies- Productivity Loss as an Alternative Perspective

    Nov 1, 2015, 00:00
  • Health Professional Students’ Willingness To Pay For Human Papillomavirus Vaccination And Factors Influencing Their Decision In Malaysia

    Nov 1, 2015, 00:00
  • Assessing The Clinical And Economic Impact Of An Automated, On-Demand Immunoassay For The Diagnosis Of Heparin Induced Thrombocytopenia

    Nov 1, 2015, 00:00
  • Pesquisa Nacional de Acesso a Medicamentos no Brasil - Percepção dos Usuários da Atenção Básica do Sistema Único de Saúde

    Nov 1, 2015, 00:00
  • A Physician-Centered Intervention To Improve Control of Blood Pressure- Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00
  • Multivariate Network Meta-Analysis- An Example In Type 2 Diabetes For The Analysis Of Glycaemic Control

    Nov 1, 2015, 00:00
  • Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

    Nov 1, 2015, 00:00
  • Strengths And Weaknesses of Current Clinical And Economic Evidence for The Comparison of Laparoscopic Versus Open Repair of Incisional Hernia

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Breast Cancer In Greece

    Nov 1, 2015, 00:00
  • Systematic Review And Meta-Analysis Of The Effectiveness And Safety Of Combination Therapy With Glycopirronium-Indacaterol Compared With Other First Line Therapies In Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2015, 00:00
  • Institutional Development Program of the Brazilian National Health System

    Nov 1, 2015, 00:00
  • Evaluation of Quality Assessment Tools for Non-Randomised Controlled Trials Assessing Surgical Interventions- A Systematic Review of Systematic Reviews

    Nov 1, 2015, 00:00
  • Quality Of Life In Adult Intradural Primary Spinal Cord Tumors- Short Form–36 Correlates With The Scales Of Mccormick And Aminoff-Logue

    Nov 1, 2015, 00:00
  • Development of a Discrete Choice Experiment to Assess Patients’ and Professionals’ Preferences for Home Enteral Nutrition

    Nov 1, 2015, 00:00
  • The Role of Selective Inhibitors of Sodium-Glucose Co-Conveyor Type 2 In Reducing of Vascular Aftereffects

    Nov 1, 2015, 00:00
  • Consistency In Search Strategies For Systematic Literature Reviews In Nice Submissions

    Nov 1, 2015, 00:00
  • Knowledge, Attitude And Practices Towards Medication Use Among Post-Graduate Pharmacy Students

    Nov 1, 2015, 00:00
  • Drug Utilization Study On Indian Elderly Ambulatory Patients Using Who Prescribing Indicators

    Nov 1, 2015, 00:00
  • Factor Consumption for Prophylaxis and Treatment of Bleeding- Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix

    Nov 1, 2015, 00:00
  • Burden Of Community-Acquired Pneumonia In Adults Over 18 Years Of Age

    Nov 1, 2015, 00:00
  • Using Geographic Information Systems and Multi-Criteria Decision Analysis to Address Spatially Explicit Problems in Healthcare Policy Decision Making

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2015, 00:00
  • Direct Medical Cost Associated With The Diagnosis and Treatment of Patients With Chronic Hepatitis-B In Three Large Metropolitan Cities In India – A Pilot Study

    Nov 1, 2015, 00:00
  • Economic Evaluation and Added Value for Stakeholders of Switching From Rituximab Intravenous Injection to Rituximab Subcutaneous Injection In France

    Nov 1, 2015, 00:00
  • Preliminary Outcomes of Health-Related Quality of Life in Hiv-Infected Naïve Patients

    Nov 1, 2015, 00:00
  • Does Conditional Marketing Authorisation Influence Market Access in France, England, and Germany?

    Nov 1, 2015, 00:00
  • A Prospective Study to Compare Safety and Efficacy of Various Anti-Glaucoma Agents and Evaluate the Effect of Aerobic Exercise on Intra-Ocular Pressure in Newly Diagnosed Primary Open Angle Glaucoma Patients in a Tertiary Care Hospital

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneous As First Line Biologic Monotherapy for Rheumatoid Arthritis Management In Greece

    Nov 1, 2015, 00:00
  • Simpson’s Paradox- Why Smoking Reduces the Risk of Dying of Cardiovascular Disease

    Nov 1, 2015, 00:00
  • Impact of Uncertainty In Predicted Risks on The Cost-Effectiveness of Risk-Stratified Preventive Treatment Strategies

    Nov 1, 2015, 00:00
  • A Comparative Study To Evaluate Treatment Patterns And Resulting Utility In Patients Of Head Neck Cancers Under Private Payment Scheme And Government Scheme

    Nov 1, 2015, 00:00
  • Expected Lifetime Numbers, Risks, And Burden of Fractures for 50-Year Old Chinese Women

    Nov 1, 2015, 00:00
  • The Economic Impact of The use of Implantable Cardioverter Defibrillator In Primary Prevention

    Nov 1, 2015, 00:00
  • Medical devices- have health technology assessment agencies started to focus more on them?

    Nov 1, 2015, 00:00
  • The Limitations of Icers In Screening Interventions and The Relative Net Benefit Alternative

    Nov 1, 2015, 00:00
  • Economic Impact of the Detection of Medication Errors in Oncological Patients with Afebrile Neutropenia in a Cancer Hospital

    Nov 1, 2015, 00:00
  • The Uk Pharmaceutical Price Regulation Scheme (Pprs) – Considerations of Voluntary Versus Statutory Regulations and How to Negotiate Pricing

    Nov 1, 2015, 00:00
  • Copd Ics/Laba Treatment Inhalers and Their Impact on Adherence

    Nov 1, 2015, 00:00
  • The Finnish Versions Of The Lower-Limb Sections Of The Toronto Extremity Salvage Score And The Musculoskeletal Tumor Society Scale- A Pilot Study

    Nov 1, 2015, 00:00
  • Budget Impact Model of Omalizumab In The Treatment of Chronic Spontaneous Urticaria In Italy

    Nov 1, 2015, 00:00
  • The Use Of Real World Evidence (Rwe) To Investigate The Overall Treatment Effects Of Different Lines Of Therapy In Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil

    Nov 1, 2015, 00:00
  • Retrospective Chart Review of Hospitalisations During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) In Italy

    Nov 1, 2015, 00:00
  • Modelo De Caracterización De Una Población Afiliada A Una Asegurada En Colombia, Mediante Una Metodología De Agrupación Por Riesgo

    Nov 1, 2015, 00:00
  • Modelling Methods for Eq-5d – a Fitting Time for Change

    Nov 1, 2015, 00:00
  • Budget Impact Analysis Of Tofacitinib For Rheumatoid Arthritis From The Perspective Of The Brazilian Private Healthcare System

    Nov 1, 2015, 00:00
  • Comparing The Cost-Effectiveness of Apcc Vs Rfviia In on-Demand Treatment of Bleeds In Hemophilia A Patients With Inhibitors- A Brazilian Public Health System Perspective

    Nov 1, 2015, 00:00
  • Efficiency of A Personalized Care Model In Diabetes As An Example of Chronic Disease With Information and Communications Technology Support

    Nov 1, 2015, 00:00
  • Apheresis Treatment In German Patients With Severe Hypercholesterolemia - A Psychodrama Market Research

    Nov 1, 2015, 00:00
  • Pulmonary Arterial Hypertension (Pah)- Real-World Treatment Patterns, Outcomes And Costs Based On World Health Organization (Who) Functional Class (Fc)

    Nov 1, 2015, 00:00
  • Association of Adherence Status As Measured Using Two Single-Item Physician-Administered Methods With Cardiovascular Risk In Patients Taking Antihypertensive Medication

    Nov 1, 2015, 00:00
  • How Important Is The Time Factor? Saving Lives Using Fire And Rescue Services

    Nov 1, 2015, 00:00
  • New Nhi Reimbursement Coverage Paradigm Called ‘Selective Reimbursement Scheme’ On The Four Major Diseases In Korea

    Nov 1, 2015, 00:00
  • Dual Bronchodilation With Qva149 In Patients With Severe And Very Severe Copd – Are There Incremental Benefits For Portuguese Patients And For The Portuguese Nhs When Compared With Current Treatment Options In Portugal?

    Nov 1, 2015, 00:00
  • Patients’ Priorities For Treatment In Moderate To Severe Copd

    Nov 1, 2015, 00:00
  • Key Drivers of Cost Effectiveness In Crohn’s Disease

    Nov 1, 2015, 00:00
  • Out Hospital Drug Consumption in Therapy of Obstructive Pulmonary Disease in Serbia in the Period from 2007 to 2012

    Nov 1, 2015, 00:00
  • Payer/Hta Requirements In Metastatic Breast Cancer

    Nov 1, 2015, 00:00
  • Cost-Effectiveness analysis of Quadrivalent Versus trivalent Influenza Vaccination In Germany — Linking a Dynamic Transmission Model with Health and Economic Outcomes

    Nov 1, 2015, 00:00
  • Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk- A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice)

    Nov 1, 2015, 00:00
  • The Use Comparative Effectiveness Research And Evidence Based Medicine In Us Payor Decision Making

    Nov 1, 2015, 00:00
  • A Comparison of Discrete Event Simulation (Des) Versus Markov Models With A Practical Application to Human-Immunodeficiency Virus (Hiv)

    Nov 1, 2015, 00:00
  • Law Project 7169/2014 And Health Policy In Brazilian Supplemetary Sector

    Nov 1, 2015, 00:00
  • How much is spent in vaccines across western europe countries?

    Nov 1, 2015, 00:00
  • Public Health Impact and cost-Effectiveness of Malaria routine Vaccination in Infants

    Nov 1, 2015, 00:00
  • Public Health and Economic Benefits of Quadrivalent Influenza Vaccine in Colombia

    Nov 1, 2015, 00:00
  • Guillain-Barre Syndrome- Clinical Presentation, Treatment Pattern And Outcome

    Nov 1, 2015, 00:00
  • Estudio de La Implementacion de la Exigencia de Bioequivalencia Sobre el Consumo de Medicamentos Durante Agosto 2009 a Noviembre 2014 en Chile

    Nov 1, 2015, 00:00
  • Qualitative Discussion on Issues of Patient-Reported Outcome Assessment in Post-Marketing Surveillance for Diseases in the Elderly

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Apremilast In Moderate to Severe Psoriasis In Scotland

    Nov 1, 2015, 00:00
  • Strategies -Based on Evidence- To Rationalize the High Cost Drugs National List in the Dominican Republic

    Nov 1, 2015, 00:00
  • Earlier Detection And Treatment of Non-Alcoholic Fatty Liver Disease- An Economic Evaluation to Appraise An Innovative Diagnostic Pathway to Detect And Intervene Where There Are Known Risk Factors

    Nov 1, 2015, 00:00
  • The Health And Medical Care Costs For Hospitalized All-Cause Pneumonia Among Children 2 Years, Pre And Postthe Introduction Of Prevenar13 In Sweden

    Nov 1, 2015, 00:00
  • Effect of Pharmacist Interventions and Patient Reported Outcomes on Highly active Antiretroviral Therapy Counseling in Indian Hiv Postive Patients - A Prospective Study

    Nov 1, 2015, 00:00
  • Costs Associated With The Management and Morbidity of Diabetic Macular Oedema and Macular Oedema Secondary to Retinal Vein Occlusion

    Nov 1, 2015, 00:00
  • The Association of Early Exposure to Phenols and Neuro-Behavior Developemnt In School-Aged Children

    Nov 1, 2015, 00:00
  • Relationship between Pain, Functional Disability and Health-Related Quality of Life in Patient with Failed Back Surgery Syndrome Undergoing Spinal Cord Stimulation- Results from the Precise Study

    Nov 1, 2015, 00:00
  • Nice Decision Making- To Appeal or not to Appeal?

    Nov 1, 2015, 00:00
  • Depression- Highlight Molecules Used in Patients from Supplementary Health in Brazil

    Nov 1, 2015, 00:00
  • Herpes Zoster and Post-Herpetic Neuralgia Vaccination- Cost-Effectiveness Analysis In Portugal

    Nov 1, 2015, 00:00
  • The Relative Efficacy And Safety Of Treatments In Second-Line Management Of Chronic Myeloid Leukaemia- Systematic Review And Network Meta-Analysis Feasibility Study

    Nov 1, 2015, 00:00
  • Persistence To Vitamin-K Antagonists (Vka) And Novel Oral Anticoagulants (Noacs) In Non-Valvular Atrial Fibrillation (Nvaf)- An Observational Study Using A Comprehensive Regional Database In Catalonia, Spain

    Nov 1, 2015, 00:00
  • Healthcare Pathways and Burden of Disease of Patients With Psoriasis and Psoriatic Arthritis

    Nov 1, 2015, 00:00
  • Real-World Patient Characteristics, Treatment Patterns, and Survival among Locally-Advanced/Metastatic Alk+ Non-Small Cell Lung Cancer Patients in Latin America

    Nov 1, 2015, 00:00
  • Epidemiology of Statin-Treated Patients with Uncontrolled Ldl Levels from Italian Administrative Official Databases

    Nov 1, 2015, 00:00
  • Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

    Nov 1, 2015, 00:00
  • Demonstrating Methods for Handling Missing Patient Reported Outcome (Pro) Data in Clinical Trial Data Analysis

    Nov 1, 2015, 00:00
  • Compound Attributes For Side Effect In Discrete Choice Experiments- Risk or Severity - What Is More Important to Hepatitis C Patients?

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Versus R-Chop for the First Line Treatment of Patients with Indolent Non-Hodgkin’s Lymphoma (Inhl) in Colombia

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of The Non-Vitamin K Antagonist Oral Anticoagulants For Atrial Fibrillation In Portugal

    Nov 1, 2015, 00:00
  • Interregional Valuation Of Patient Satisfaction With Pharmaceutical Care As A Tool For Increasing Quality Management In Community Pharmacy And Patients Quality Of Life

    Nov 1, 2015, 00:00
  • Cost of Medication Nonadherence in Patients with Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Complementary and Alternative Medicines (Cam) Among Diabetes Patients- A Prospective Study From Pakistan

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Recommended Medical Intervention for Treatment of Dysmenorrhea and Endometriosis in Japan Setting

    Nov 1, 2015, 00:00
  • Estimating The Supply And Demand Of Butantan Dengue Vaccine In Brazil

    Nov 1, 2015, 00:00
  • Content Validity of the Current Health Satisfaction Questionnaire (Ches-Q) Among People Living with Type 2 Diabetes Mellitus (T2dm) and Comorbid Chronic Kidney Disease (Ckd)

    Nov 1, 2015, 00:00
  • How to Handle Levels of Evidence In Health Economic Modelling

    Nov 1, 2015, 00:00
  • Quality Of Life Of Patients Experiencing Cancer-Associated Thrombosis

    Nov 1, 2015, 00:00
  • Costo En Salud En La Intervenci”N De Suplemento De Hierro En Niños De 6 A Menos De 36 Meses De Edad Para Reducir La Anemia En El Perú, 2009-2014

    Nov 1, 2015, 00:00
  • The Italian Regional Access of New Cancer Drugs- An Example in Four Regions

    Nov 1, 2015, 00:00
  • Costo-Efectividad De Octreotide Lar Comparado Con Terapia De Soporte Usual Para El Tratamiento De Tumores Neuroendocrinos De Intestino Medio En Colombia

    Nov 1, 2015, 00:00
  • Patient-Reported Outcomes In Studies Published In 2014- Which Tools Have Been Most Commonly Used In Studies Of Respiratory Disorders?

    Nov 1, 2015, 00:00
  • Treatment Patterns and Health Care Resource use (Hcru) Associated with Repeatedly Treated Metastatic Squamous Cell Carcinoma of the Head and Neck (Scchn) in the United Kingdom (Uk)

    Nov 1, 2015, 00:00
  • Asociación Significativa Entre La Enfermedad Voluminosa Cercana A Craneo Y Neuroeje Y La Infiltración Secundaria A Sistema Nervioso Central En Pacientes Con Linfoma Difuso De Células Grandes B

    Nov 1, 2015, 00:00
  • Investigating Levels of Bacterial Resistance and Antibiotic Consumption in the St. Petersburg State Medical University

    Nov 1, 2015, 00:00
  • Economic Burden of Patients with Alk+ Mutation non-Small Cell Lung Cancer After Treatment with Crizotinib- a Canadian Retrospective Observational Study

    Nov 1, 2015, 00:00
  • Clinician-Reported Insights of Insulin Degludec Use In Germany and Four Supporting European Countries

    Nov 1, 2015, 00:00
  • A Network Metanalysis Comparing The Efficacy of Biologics for The Treatment of Early Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Economic Evaluation of The One-Step Scheme Compared With Two-Steps for Screening And Diagnosis of Gestational Diabetes In Colombia

    Nov 1, 2015, 00:00
  • Use of A Multi-Decision Criteria Analysis to Support Healthcare Decision-Making for Private Payers in Brazil- Development of a Model To Guide Reimbursement Decisions

    Nov 1, 2015, 00:00
  • Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013

    Nov 1, 2015, 00:00
  • How Insurance Claim Data Can Help in Health Outcomes Research- an Indian Perspective

    Nov 1, 2015, 00:00
  • Market Access Trends In Rare Disease Approvals In Europe From 2005 To 2014

    Nov 1, 2015, 00:00
  • Cost-Minimization Analysis and Total Cost Analysis for A Weight Range In Crohn’s Disease Treatment With Anti-Tnf Biologics Under Brazilian Private Health Care System Perspective

    Nov 1, 2015, 00:00
  • Envelhecimento Populacional E As Políticas Públicas De Saúde No Brasil

    Nov 1, 2015, 00:00
  • Analysis of Biotechnology Drugs Market in Turkey

    Nov 1, 2015, 00:00
  • Patterns of Care For Metastatic Pancreatic Cancer- Real World Data From The Brazilian Private Health System (Phs)

    Nov 1, 2015, 00:00
  • Network Meta-Analysis of Survival Data Using Fractional Polynomials – an Example with First Line Metastatic Renal cell cancer Treatments

    Nov 1, 2015, 00:00
  • Simulating The Impact Of A Cardiovascular Prevention Program

    Nov 1, 2015, 00:00
  • Patent Expiry and Generic Pricing- The Impact on Cost- Effectiveness Results

    Nov 1, 2015, 00:00
  • Public Health and Economic Benefits of Quadrivalent Influenza Vaccine in Panama

    Nov 1, 2015, 00:00
  • Health-Related Quality of Life of People From Low-Income Families In Hong Kong, China

    Nov 1, 2015, 00:00
  • Healthcare Resource Consumption and Cost of Care In Patients With Autosomal Dominant Polycystic Disease (Adpkd) In Italy

    Nov 1, 2015, 00:00
  • Comparable Analysis of Prices for First Stage of Dental Implantation In Ukraine

    Nov 1, 2015, 00:00
  • Evaluation of Fractures In The Elderly In Austria And Drug Risk Factor Analysis Based on Claims Data

    Nov 1, 2015, 00:00
  • The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden

    Nov 1, 2015, 00:00
  • Risk Factors for Developing Diabetes As A Determinant of The Cost-Effectiveness of Using Coronary Calcium Score to Guide Primary Prevention With Statins

    Nov 1, 2015, 00:00
  • Diagnosis of Liver Diseases Among Individual With Hepatic Dysfunction Detected By Annual Health Checkup Based on Claims Data In Japan

    Nov 1, 2015, 00:00
  • Willingness to Pay for One Quality Adjusted Life Years In Patients With Diabetes

    Nov 1, 2015, 00:00
  • A Systematic Review Of Cardiovascular Event Utilities In Europe

    Nov 1, 2015, 00:00
  • Need for New Pharmacoeconomics Policy for Regulating Prices of Medical Devices In India

    Nov 1, 2015, 00:00
  • Beyond The Middle- Evaluating Surrogacy Of Clinical Trial Endpoints Across Trial Durations

    Nov 1, 2015, 00:00
  • Análise da Produção de Avaliação de Tecnologias Em Saúde do Centro Colaborador do Sistema Único de Saúde (Sus), Brasil - Uma Parceria Entre o Governo E A Academia

    Nov 1, 2015, 00:00
  • Analysis of Four Early Dialogues (ED) as Part of the Seed (Shaping European Early Dialogues) Pilot- Lessons Learnt and Way Forward. Sanofi’s Perspective

    Nov 1, 2015, 00:00
  • Costo Efectividad Y Costo Utilidad Del Uso De Undecanoato De Testosterona Inyectable En Pacientes Con Hipogonadismo Y Diabetes Mellitus Tipo 2 En Colombia

    Nov 1, 2015, 00:00
  • Effect Of Fingolimod On Disease Progressions, Relapse Rate And Brain Atrophy In Multiple Sclerosis Patients- Review Of Literature And Pharmacoeconomic Considerations

    Nov 1, 2015, 00:00
  • Twenty-Year Trends In Diagnosis and Treatment of Alzheimer’s Disease

    Nov 1, 2015, 00:00
  • Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages

    Nov 1, 2015, 00:00
  • Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Health Care Resource Utilization In Asthma

    Nov 1, 2015, 00:00
  • The Analysis of Inpatients Cost of Breast Cancer in China, 2011

    Nov 1, 2015, 00:00
  • Following Norway, Which Market Will Be Next to See Extreme Biosimilar Discounting?

    Nov 1, 2015, 00:00
  • Psychometric Validation of the New International Questionnaire to Assess Health-Related Quality of Life (Hrql) Specific to Viral Hepatitis C- Proqol-Hcv

    Nov 1, 2015, 00:00
  • Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) with Nilotinib as the Second-Line Treatment in Russian Federation

    Nov 1, 2015, 00:00
  • The Cost of Treating Recurrent Clostridium Difficile Infection In Patients Attending Infectious Disease Clinics At Four Hospitals In Sweden

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Omalizumab In Chronic Spontaneous Urticaria In The Netherlands

    Nov 1, 2015, 00:00
  • The Analyze of Consumption of Fixed Combinations of Drugs in Therapy of Hypertension

    Nov 1, 2015, 00:00
  • The Cost of Molecular Diagnostic Testing in Oncology – a Workflow Analysis

    Nov 1, 2015, 00:00
  • A Description Of Real-World Treatment With Abiraterone Acetate In Metastatic Castration-Resistant Prostate Cancer Patients In The Post-Chemotherapy Setting In France And The Netherlands

    Nov 1, 2015, 00:00
  • A New Methodology to Define the Scope of The French « Liste-En-Sus »

    Nov 1, 2015, 00:00
  • Impact of Overweight and Obesity in the Frequency Medical Complications During Pregnancy and Economic Burden in the High Risk Pregnancy in Mexico

    Nov 1, 2015, 00:00
  • Connection Between the way of Parenting and the Behavior of Adolescents in the Light of a Survey in Hungary

    Nov 1, 2015, 00:00
  • Identification of Factors Involved In Medication Complian Incorrect Inhaler Technique of Asthma Treatment Leads to Poor Compliance

    Nov 1, 2015, 00:00
  • Gender Differences in Physical Activity of Hungarian Adults- An Observatory Survey

    Nov 1, 2015, 00:00
  • Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, Through The Patient Assessment Of Chronic Illness Care Questionnaire

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Potential Campylobacter Control Measures in the Food Chain of Indoor Broiler Chicken in the Eu

    Nov 1, 2015, 00:00
  • Happiness Effects on Health-State Valuations

    Nov 1, 2015, 00:00
  • Differences In Disease Specific Hrqol In Rrms Patients Initiated on Oral Dmf Or Platform Therapies In Europe And Us

    Nov 1, 2015, 00:00
  • Cost Analysis of Residual Viremia Detected by Two Real-Time Pcr Assays For Response-Guided (Dual Or Triple) Therapy of Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00
  • Patient Involvement with Pharmaceutical Industry Drug Development and Research- A Review of the Literature

    Nov 1, 2015, 00:00
  • Methods to Account for Follow-Up Time Differences when Calculating Qalys from Randomised Controlled Trials

    Nov 1, 2015, 00:00
  • Cost-Utility of Bariatric Surgery In France And Germany

    Nov 1, 2015, 00:00
  • The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00
  • A Novel Method for Calculating Medication Adherence to Poly-Pharmacotherapy by Linking General Practice Prescribing Data and Pharmacy Dispensing Records

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective

    Nov 1, 2015, 00:00
  • Method Comparison Of Censoring Cost Analyses

    Nov 1, 2015, 00:00
  • Adaptive Pathways May Expand The Gap Between Regulators And Payers

    Nov 1, 2015, 00:00
  • A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy

    Nov 1, 2015, 00:00
  • Measuring Health Care Performance on Equity- A Framework Using National Administrative Data from 2004/5 to 2011/12

    Nov 1, 2015, 00:00
  • Treatment Outcomes Among Hiv/Aids Patients Treated During Haart Therapy At Infectious Disease Clinic

    Nov 1, 2015, 00:00
  • Utility And Metrics Of Natural Language Processing On Identifying Patients For Pharmacoepidemiologic Studies

    Nov 1, 2015, 00:00
  • Assessing Heterogeneity Across Groups of Clinical Trials Based on Aggregate Data

    Nov 1, 2015, 00:00
  • Drug Pricing Reform in China - Impact of the Reform from a Societal Perpsective

    Nov 1, 2015, 00:00
  • Effectiveness of A Community-Based Falls Prevention Program For The Elderly

    Nov 1, 2015, 00:00
  • Measuring the Impact of Multiple Sclerosis- Enhancing the Performance of the Msis-29 and Msws-12

    Nov 1, 2015, 00:00
  • Nuevas Moléculas Registradas En Chile Durante El Año 2014

    Nov 1, 2015, 00:00
  • Análisis de Costo-Efectividad de Las Vacuna Antineumocóccicas Conjugadas en Colombia

    Nov 1, 2015, 00:00
  • Progressive Innovation in Oncology- Valuing Outcomes Beyond Survival

    Nov 1, 2015, 00:00
  • Direct Cost and Medication Usage in Elderly Type 2 Diabetic Patients under Hospitalization among Insured Urban Population in China

    Nov 1, 2015, 00:00
  • Market Access Entry Agreements in the Italian Market Between January 2006 and April 2015

    Nov 1, 2015, 00:00
  • Custo-Efetividade Do Tenofovir Para O Tratamento Da Hepatite B Crônica Uma Revisão Sistemática

    Nov 1, 2015, 00:00
  • The Cost Effectiveness of Agomelatine in the Treatment of Major Depressive Disorder

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Cerebrolysin In The Treatment of Patients With Acute Ischemic Stroke Moderate and Severe Degrees of Severity In The Russian Federation

    Nov 1, 2015, 00:00
  • What Lifecycle Management Lessons Can We Learn From Pd-1 Immuno-Oncology Therapies?

    Nov 1, 2015, 00:00
  • Clinical And Economic Burden Of Asthma And Chronic Obstructive Pulmonary Disease (Copd) In Poland- Estimated Impact Of Poor Inhalation Technique With Inhaled Corticosteroid And Long-Acting Beta Agonist Fixed-Dose Combinations

    Nov 1, 2015, 00:00
  • Experienced Vs. Hypothetical Health States Preferences Using Eq-5d 3l And 5l Versions- A National Study

    Nov 1, 2015, 00:00
  • Comparison Of Overall Costs Between Alprostadil And Limb Amputation In Patients Affected By Peripheral Arterial Disease Stages Iii And Iv In Mexico

    Nov 1, 2015, 00:00
  • Does Budget Impact Affect Reimbursement Decisions Made by the Cancer Drugs Fund in England?

    Nov 1, 2015, 00:00
  • Does Crgs Provide Proper Guides for An Efficient Pharmaceutical Prescription In Alzheimer Patients?

    Nov 1, 2015, 00:00
  • Instructions for Authors

    Nov 1, 2015, 00:00
  • The Public Health Impact and Cost-Effectiveness of Pneumococcal Conjugate Vaccination In Estonia

    Nov 1, 2015, 00:00
  • Economic Burden In Studies Published In 2014- What Type of Gastrointestinal Disorders, Interventions and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00
  • Barriers to Intensification of Insulin Treatment In Patients With Type 2 Diabetes In The Netherlands- Assessing Patient Preferences And Behaviours

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of Botulinum Toxin Type A Treatment for Cerebral Palsy In The Russian Federation

    Nov 1, 2015, 00:00
  • Use of Health Services In Brazil- A Systematic Review And Meta-Analysis of Prevalence Studies

    Nov 1, 2015, 00:00
  • Efficacy of Surgical Vs. Non-Surgical Treatment of Carpal Tunnel Syndrome (Cts)- A Systematic Review

    Nov 1, 2015, 00:00
  • Systematic Review of Fda Breakthrough Therapy Designated Products

    Nov 1, 2015, 00:00
  • Long-Term Eq-5d Score For Patients With Metastatic Breast Cancer; Comparison Of First-Line Oral S-1 And Taxane Therapies In The Randomized “Select” Trial

    Nov 1, 2015, 00:00
  • Treatment Patterns, Resource Utilization And Costs In Muscular Dystrophy Patients- Analysis Using Administrative Claims Data

    Nov 1, 2015, 00:00
  • Knowledge, Attitude and Perception of Polio (Poliomyelitis) among General Public in Pakistan

    Nov 1, 2015, 00:00
  • Variability in Clinical Comparators and Standards of Care- Consequences for Pan-European Relative Efficacy

    Nov 1, 2015, 00:00
  • Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation

    Nov 1, 2015, 00:00
  • A Systematic Literature Review To Identify And Compare Clinical Trials Evaluating Novel Therapeutic Agents In Post-Gemcitabine Advanced Pancreatic Cancer

    Nov 1, 2015, 00:00
  • Clinical Trial Trends in Latin America- communicable Versus Non-Communicable Disease

    Nov 1, 2015, 00:00
  • Análisis Comparativo De Los Procesos De Decisión De Cobertura De Medicamentos Para Enfermedades Raras En Los Países De La Ocde

    Nov 1, 2015, 00:00
  • Modeling the cost-effectiveness of a new covered stent (willis) vs. Endovascular coil occlusion for the treatment of intracranial aneurysms in china

    Nov 1, 2015, 00:00
  • Validating Approaches to Modelling End-Stage Renal Disease Using The Ims Core Diabetes Model

    Nov 1, 2015, 00:00
  • Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation Among People With Type 2 Diabetes Mellitus In Japan

    Nov 1, 2015, 00:00
  • Analysis Of Differences In Hta Reimbursement Decisions Of Stage Iv (Metastatic) Breast Cancer Medications Across Different Countries

    Nov 1, 2015, 00:00
  • Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain

    Nov 1, 2015, 00:00
  • Daclatasvir +Asunaprevir Versus Sofosbuvir/Ledipasvir for The Treatment of Chronic Hepatitis C Genotype 1 In Japanese Patients- A Matching-Adjusted Indirect Comparison

    Nov 1, 2015, 00:00
  • Cambios En La Percepción De La Calidad De Vida Relacionada Con La Salud Por Diferencias En El Acceso Y El Régimen De Afiliación En Bogotá

    Nov 1, 2015, 00:00
  • A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Minimun Indicators To Evaluate Management and Clinical Results in Institutions Assisting Patients Living with Hiv in Colombia

    Nov 1, 2015, 00:00
  • Prescription Algorithms- Impact On Statins

    Nov 1, 2015, 00:00
  • Disinvesting In Low-Value Care- Opportunities And Challenges

    Nov 1, 2015, 00:00
  • A Cross-Sectional Study on Insulin Treatments and Glycemic Control in Type 2 Diabetes in France, Italy, Germany, UK and Spain

    Nov 1, 2015, 00:00
  • Heterogeneity in the Definition of Drug Induced Hypoglycemia in Clinical Trials- A Review

    Nov 1, 2015, 00:00
  • Avaliaçao das Demandas da Isotretinoína Para o Tratamento da Acne Grave no Sistema Único de Saúde (Sus), Brasil

    Nov 1, 2015, 00:00
  • The Economic Burden of Primary Brain Tumors in Canada

    Nov 1, 2015, 00:00
  • Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Bariatric Surgery for The Treatment of Obesity In Australia

    Nov 1, 2015, 00:00
  • Female Breast Cancer- Burden Of Disease In Portugal

    Nov 1, 2015, 00:00
  • Years of Working Life Lost Caused By Osteoarthritis In Portugal

    Nov 1, 2015, 00:00
  • Relationship Between Patient Characteristics and Outcomes In Patients With Multiple Myeloma

    Nov 1, 2015, 00:00
  • Epidemiology and Burden of Multiple Myeloma in Japan- a Systematic Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Modelling for Neuropathic Pain Treatments- An Exploration to Identify Comparative Importance of Model Parameters

    Nov 1, 2015, 00:00
  • Thermodilution Technique For Vascular Access Flow Measurement- A Systematic Review

    Nov 1, 2015, 00:00
  • Evaluating The Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus In Liver Transplant Patients Based on Data From Routine Clinical Practice

    Nov 1, 2015, 00:00
  • Adherence and Persistence to Allopurinol among Hypertensive Patients with Gout

    Nov 1, 2015, 00:00
  • Epidemiology And Healthcare Services Utilization for Rare Diseases In Italy

    Nov 1, 2015, 00:00
  • Evaluación De Costo De Efectividad Y Costo Utilidad Del Uso De Rivaroxabán En Pacientes Sometidos Quirúrgicamente Por Reemplazo De Cadera Y Rodilla, Frente A Enoxaparina En El Contexto Ecuatoriano

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)

    Nov 1, 2015, 00:00
  • Comparative Effectiveness Of Granulocyte Colony-Stimulating Factors (G-Csf) For Reducing Incidence Of Febrile Neutropenia (Fn) –Related Hospitalization- A Retrospective Cohort Study Using German Claims Data

    Nov 1, 2015, 00:00
  • The Vaccine Portfolio Management Model as an Efficiency Tool for Japan

    Nov 1, 2015, 00:00
  • Reducing Consumption Versus Maintaining Abstinen Market Access Challenges Facing a Novel Treatment Pathway for Alcohol Addiction in the Eu5

    Nov 1, 2015, 00:00
  • Scoring and Responsiveness of the Self-Assessment of Treatment Version Ii Questionnaire in Patients with Painful Diabetic Peripheral Neuropathy

    Nov 1, 2015, 00:00
  • Hta Studies for Medical Devices Incorporating Their Moral Ageing

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Increasing the Influenza Vaccination Rate in Adults with Type 2 Diabetes in Turkey

    Nov 1, 2015, 00:00
  • Will Rating Scale Types And Disease Conditions Influence Concordance Between Cognitive Function Reported By Children And Their Parents?

    Nov 1, 2015, 00:00
  • Economic Impact Of Drug-Related Morbidity In Sweden

    Nov 1, 2015, 00:00
  • Pricing Policy for Pharmaceuticals in Egypt- Challenges and Opportunities

    Nov 1, 2015, 00:00
  • Are you at risk of cancer? Consider Where you live in england for Access to the Most Expensive Oncology Treatments

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Rituximab in Treatmenting Diffuse Large B-Cell Lymphoma in China

    Nov 1, 2015, 00:00
  • Patient Reported Outcomes (Pro) in Postprogression Oncology- Implications in Health Technology Assessments (Hta) Payer Decision Making

    Nov 1, 2015, 00:00
  • Economic Burden Of Adpkd From The Spanish Health System And Patient’s Perspective- Advantages Of Delaying Dialysis

    Nov 1, 2015, 00:00
  • Examination of Stress and Psychosomatic Symptoms In Terms of Nurses’ Quality of Life

    Nov 1, 2015, 00:00
  • Assessing Copd Patients Burden Of Disease In A Fold-In-Fold-Out Discrete Choice Experiment

    Nov 1, 2015, 00:00
  • Ethical Requirements for the Conduct of Drug Utilisation Studies Involving AD Hoc Data Collection- An International Cross-Sectional Survey

    Nov 1, 2015, 00:00
  • Predicting The Future Economic Burden of Hip Fractures In Norway-The Impact of Epidemiological Uncertainty

    Nov 1, 2015, 00:00
  • Mapping The St George’s Respiratory Questionnaire To The Euroqol 5 Dimensions- A Study In Patients With Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00
  • Impact of Decision Making Based on The Matching The Quality of The Early Warning Indicators In Colombia During 2013 – 2014 Between Private And Public Ips and The Quantity of Affiliates By Regimen

    Nov 1, 2015, 00:00
  • Evolution Of The Number Of Patients Treated For Metastatic Cancer Between 2003 And 2013 In France

    Nov 1, 2015, 00:00
  • Is Edoxaban A Cost-Effective Alternative To Venous Thromboembolim Patients Treated With Vitamin K Antagonists In Spain?

    Nov 1, 2015, 00:00
  • Therapy Adherence In Patients With Multiple Sclerosis Using An Electronic Multidose Auto-Injection Device

    Nov 1, 2015, 00:00
  • Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites

    Nov 1, 2015, 00:00
  • The Impact of Orthopaedic Surgery on The Quality of Life of Haemophilia Patients With or Without Inhibitors- A Systematic Review of The Literature

    Nov 1, 2015, 00:00
  • Adherence and Persistence In Patients Initiating Treatment With Injectable Therapies for Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2015, 00:00
  • Matters of Weight- Financial Burden of Overweight and Obesity in Mexico

    Nov 1, 2015, 00:00
  • Apixaban In Patients With Atrial Fibrillation- Patient Characteristics Of The Latin America Cohort From A Multinational Clinical Trial

    Nov 1, 2015, 00:00
  • Comparative Efficacy Of Ketamine And Other Pharmacological And Somatic Interventions In Adult Patients With Treatment-Resistant Depression- A Network Meta-Analysis

    Nov 1, 2015, 00:00
  • Sensitivity Analysis- How Much Impact Does It Have on The Nice Decision Making Process?

    Nov 1, 2015, 00:00
  • Eunethta Members- What are their Roles within the National Setting?

    Nov 1, 2015, 00:00
  • Breast Cancer Patients’ Perception On Health Impacts From Receiving Chemotherapy

    Nov 1, 2015, 00:00
  • Economic, Public Health, and Humanistic Impact of a Quadrivalent Human Papillomavirus (Hpv6/11/16/18) Vaccination Program for Females Age 9-11 Years in Mexico

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86 (current)
  • 87
  • 88
  • 89
  • 90
  • »